home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  Cambridge Healthtech Institute's Intelligent Drug Discovery and Development 2003  
  January 28, 2003

Biotechnology

 
     
  Cambridge Healthtech Institute, Wyndham Franklin Plaza Hotel, 17th and Race Streets, Philadelphia, PA 19103
May 28-30, 2003


New In 2003!
Innovative screening approaches
Literature data mining
Metabolic profiling
Novel targets vs. novel chemistry
Pre- and post-conference tutorials

Presentations from 14 of the top pharmaceutical companies in the world*
Pfizer
Johnson & Johnson
GlaxoSmithKline
Novartis
Merck
Eli Lilly
Amgen
Pharmacia AstraZeneca
Bristol-Myers Squibb
Aventis
Schering-Plough
Hoffmann-La Roche
Genentech

*MedAdNews, 2002

 
 
Organized by: Cambridge Healthtech Institute
Invited Speakers: Dr. Lee E. Babiss,
Vice President of
Preclinical R&D
Hoffmann-La Roche, Inc
Dr. Peter Jurs,
Chemistry Department,
Penn State University
Dr. George Scangos
Chief Executive Officer,
Exelexis, Inc.
Dr. Daniel Shirlin,
Head of Global Lead Generation, Aventis DI&A
 
Deadline for Abstracts: April 11, 2003
 
Registration: REGISTER BY FEBRUARY 7 AND SAVE $300!!! Call 617-630-1300 (fax 617-630-1325) and ask for the registration department. or e-mail chi@healthtech.com Also registration is available online
E-mail: eeskedal@healthtech.com
 
  Posted by:   Elaine Eskedal  
Host: wks152.healthtech.com
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.